Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

BUY
$42.05 - $47.77 $3,574 - $4,060
85 Added 0.99%
8,703 $379,000
Q1 2022

Apr 29, 2022

SELL
$40.23 - $47.74 $28,965 - $34,372
-720 Reduced 7.71%
8,618 $376,000
Q4 2021

Jan 27, 2022

SELL
$38.88 - $45.31 $27,216 - $31,717
-700 Reduced 6.97%
9,338 $412,000
Q3 2021

Oct 18, 2021

SELL
$38.79 - $43.16 $14,041 - $15,623
-362 Reduced 3.48%
10,038 $383,000
Q2 2021

Jul 28, 2021

SELL
$36.52 - $41.46 $4,747 - $5,389
-130 Reduced 1.23%
10,400 $414,000
Q1 2021

Apr 08, 2021

SELL
$34.27 - $40.01 $66,243 - $77,339
-1,933 Reduced 15.51%
10,530 $376,000
Q3 2020

Oct 29, 2020

SELL
$38.11 - $42.99 $6,669 - $7,523
-175 Reduced 1.38%
12,463 $470,000
Q1 2020

Apr 23, 2020

SELL
$32.47 - $48.83 $32,470 - $48,830
-1,000 Reduced 7.33%
12,638 $478,000
Q3 2019

Nov 12, 2019

SELL
$40.46 - $43.52 $54,742 - $58,882
-1,353 Reduced 9.03%
13,638 $582,000
Q2 2019

Aug 07, 2019

SELL
$39.4 - $42.7 $3,940 - $4,270
-100 Reduced 0.66%
14,991 $600,000
Q1 2019

May 06, 2019

SELL
$38.57 - $42.69 $38,570 - $42,690
-1,000 Reduced 6.21%
15,091 $631,000
Q4 2018

Feb 14, 2019

SELL
$37.8 - $42.69 $67,737 - $76,500
-1,792 Reduced 10.02%
16,091 $615,000
Q3 2018

Nov 09, 2018

SELL
$39.75 - $42.69 $14,310 - $15,368
-360 Reduced 1.97%
17,883 $718,000
Q2 2018

Jul 31, 2018

SELL
$39.61 - $42.76 $14,338 - $15,479
-362 Reduced 1.95%
18,243 $735,000
Q1 2018

May 22, 2018

SELL
$36.18 - $40.15 $74,024 - $82,146
-2,046 Reduced 9.91%
18,605 $727,000
Q4 2017

Feb 14, 2018

SELL
$35.34 - $41.9 $17,740 - $21,033
-502 Reduced 2.37%
20,651 $732,000
Q3 2017

Nov 07, 2017

SELL
$39.44 - $41.55 $45,434 - $47,865
-1,152 Reduced 5.16%
21,153 $859,000
Q2 2017

Aug 08, 2017

BUY
N/A
22,305
22,305 $962,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Nbt Bank N A Portfolio

Follow Nbt Bank N A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbt Bank N A , based on Form 13F filings with the SEC.

News

Stay updated on Nbt Bank N A with notifications on news.